Listed

Werewolf Therapeutics, Inc.

HOWLNasdaqCIK 1785530HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Operating income$7.2m, Q2 FY2026
Net income$3.7m, Q2 FY2026
Werewolf Therapeutics, Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Research and development$m10.8Research and development, Q3 FY2023, three months to 2023-09-30$10.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-07, accession 0001785530-24-000034.Report this figure9.6Research and development, Q4 FY2023, three months to 2023-12-31$9.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-11, accession 0001785530-25-000008. Derived: 12-month figure less the 9-month figure.Report this figure12.9Research and development, Q1 FY2024, three months to 2024-03-31$12.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-08, accession 0001785530-25-000014.Report this figure15.3Research and development, Q2 FY2024, three months to 2024-06-30$15.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-14, accession 0001785530-25-000021.Report this figure12.5Research and development, Q3 FY2024, three months to 2024-09-30$12.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-04, accession 0001785530-25-000031.Report this figure15.7Research and development, Q4 FY2024, three months to 2024-12-31$15.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-27, accession 0001785530-26-000006. Derived: 12-month figure less the 9-month figure.Report this figure13.1Research and development, Q1 FY2025, three months to 2025-03-31$13.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-07, accession 0001785530-26-000012.Report this figure13.1Research and development, Q2 FY2025, three months to 2025-06-30$13.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-07-31, accession 0001785530-26-000019.Report this figure11.6Research and development, Q3 FY2025, three months to 2025-09-30$11.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-04, accession 0001785530-25-000031.Report this figure6.9Research and development, Q4 FY2025, three months to 2025-12-31$6.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-27, accession 0001785530-26-000006. Derived: 12-month figure less the 9-month figure.Report this figure8.2Research and development, Q1 FY2026, three months to 2026-03-31$8.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-07, accession 0001785530-26-000012.Report this figure6.2Research and development, Q2 FY2026, three months to 2026-06-30$6.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-07-31, accession 0001785530-26-000019.Report this figure
Operating income$m(9.3)Operating income, Q3 FY2023, three months to 2023-09-30−$9.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-07, accession 0001785530-24-000034.Report this figure(13.0)Operating income, Q4 FY2023, three months to 2023-12-31−$13.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-11, accession 0001785530-25-000008. Derived: 12-month figure less the 9-month figure.Report this figure(17.2)Operating income, Q1 FY2024, three months to 2024-03-31−$17.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-08, accession 0001785530-25-000014.Report this figure(19.0)Operating income, Q2 FY2024, three months to 2024-06-30−$19.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-14, accession 0001785530-25-000021.Report this figure(17.1)Operating income, Q3 FY2024, three months to 2024-09-30−$17.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-04, accession 0001785530-25-000031.Report this figure(20.3)Operating income, Q4 FY2024, three months to 2024-12-31−$20.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-27, accession 0001785530-26-000006. Derived: 12-month figure less the 9-month figure.Report this figure(18.0)Operating income, Q1 FY2025, three months to 2025-03-31−$18.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001785530-26-000012.Report this figure(17.5)Operating income, Q2 FY2025, three months to 2025-06-30−$17.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-07-31, accession 0001785530-26-000019.Report this figure(15.7)Operating income, Q3 FY2025, three months to 2025-09-30−$15.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-04, accession 0001785530-25-000031.Report this figure(9.4)Operating income, Q4 FY2025, three months to 2025-12-31−$9.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-27, accession 0001785530-26-000006. Derived: 12-month figure less the 9-month figure.Report this figure(13.3)Operating income, Q1 FY2026, three months to 2026-03-31−$13.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001785530-26-000012.Report this figure7.2Operating income, Q2 FY2026, three months to 2026-06-30$7.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-07-31, accession 0001785530-26-000019.Report this figure
Interest expense$m1.0Interest expense, Q3 FY2023, three months to 2023-09-30$1.0m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2024-11-07, accession 0001785530-24-000034.Report this figure1.0Interest expense, Q4 FY2023, three months to 2023-12-31$1.0m. XBRL concept us-gaap:InterestExpense. 10-K filed 2024-03-07, accession 0001785530-24-000012. Derived: 12-month figure less the 9-month figure.Report this figure1.0Interest expense, Q1 FY2024, three months to 2024-03-31$1.0m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-05-03, accession 0001785530-24-000020.Report this figure1.1Interest expense, Q2 FY2024, three months to 2024-06-30$1.1m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-08-14, accession 0001785530-25-000021.Report this figure1.2Interest expense, Q3 FY2024, three months to 2024-09-30$1.2m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-04, accession 0001785530-25-000031.Report this figure1.3Interest expense, Q4 FY2024, three months to 2024-12-31$1.3m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-03-27, accession 0001785530-26-000006. Derived: 12-month figure less the 9-month figure.Report this figure1.3Interest expense, Q1 FY2025, three months to 2025-03-31$1.3m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-07, accession 0001785530-26-000012.Report this figure1.3Interest expense, Q2 FY2025, three months to 2025-06-30$1.3m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-07-31, accession 0001785530-26-000019.Report this figure1.3Interest expense, Q3 FY2025, three months to 2025-09-30$1.3m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-04, accession 0001785530-25-000031.Report this figure1.4Interest expense, Q4 FY2025, three months to 2025-12-31$1.4m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-03-27, accession 0001785530-26-000006. Derived: 12-month figure less the 9-month figure.Report this figure1.4Interest expense, Q1 FY2026, three months to 2026-03-31$1.4m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-07, accession 0001785530-26-000012.Report this figure0.5Interest expense, Q2 FY2026, three months to 2026-06-30$475.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-07-31, accession 0001785530-26-000019.Report this figure
Net income$m(8.3)Net income, Q3 FY2023, three months to 2023-09-30−$8.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-07, accession 0001785530-24-000034.Report this figure(12.0)Net income, Q4 FY2023, three months to 2023-12-31−$12.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-11, accession 0001785530-25-000008. Derived: 12-month figure less the 9-month figure.Report this figure(16.2)Net income, Q1 FY2024, three months to 2024-03-31−$16.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-04, accession 0001785530-25-000031.Report this figure(17.2)Net income, Q2 FY2024, three months to 2024-06-30−$17.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-04, accession 0001785530-25-000031.Report this figure(16.7)Net income, Q3 FY2024, three months to 2024-09-30−$16.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-04, accession 0001785530-25-000031.Report this figure(20.4)Net income, Q4 FY2024, three months to 2024-12-31−$20.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-27, accession 0001785530-26-000006. Derived: 12-month figure less the 9-month figure.Report this figure(18.1)Net income, Q1 FY2025, three months to 2025-03-31−$18.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-07-31, accession 0001785530-26-000019.Report this figure(18.0)Net income, Q2 FY2025, three months to 2025-06-30−$18.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-07-31, accession 0001785530-26-000019.Report this figure(16.4)Net income, Q3 FY2025, three months to 2025-09-30−$16.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-04, accession 0001785530-25-000031.Report this figure(8.4)Net income, Q4 FY2025, three months to 2025-12-31−$8.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-27, accession 0001785530-26-000006. Derived: 12-month figure less the 9-month figure.Report this figure(13.5)Net income, Q1 FY2026, three months to 2026-03-31−$13.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-07-31, accession 0001785530-26-000019.Report this figure3.7Net income, Q2 FY2026, three months to 2026-06-30$3.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-07-31, accession 0001785530-26-000019.Report this figure
Diluted EPS$ per share(0.23)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.23 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-07, accession 0001785530-24-000034.Report this figurenot reported(0.39)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.39 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-08, accession 0001785530-25-000014.Report this figure(0.43)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.43 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-14, accession 0001785530-25-000021.Report this figure(0.38)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.38 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-04, accession 0001785530-25-000031.Report this figurenot reported(0.40)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.40 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001785530-26-000012.Report this figure(0.40)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.40 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-07-31, accession 0001785530-26-000019.Report this figure(0.36)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.36 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-04, accession 0001785530-25-000031.Report this figurenot reported(0.28)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.28 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001785530-26-000012.Report this figure0.08Diluted EPS, Q2 FY2026, three months to 2026-06-30$0.08 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-07-31, accession 0001785530-26-000019.Report this figure
Basic EPS$ per share(0.23)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.23 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-07, accession 0001785530-24-000034.Report this figurenot reported(0.39)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.39 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-08, accession 0001785530-25-000014.Report this figure(0.40)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.40 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-14, accession 0001785530-25-000021.Report this figure(0.38)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.38 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-04, accession 0001785530-25-000031.Report this figurenot reported(0.40)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.40 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-07, accession 0001785530-26-000012.Report this figure(0.40)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.40 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-07-31, accession 0001785530-26-000019.Report this figure(0.36)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.36 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-04, accession 0001785530-25-000031.Report this figurenot reported(0.28)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.28 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-07, accession 0001785530-26-000012.Report this figure0.08Basic EPS, Q2 FY2026, three months to 2026-06-30$0.08 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-07-31, accession 0001785530-26-000019.Report this figure

Balance sheet

Cash and equivalents$22.0m, Q2 FY2026
Long-term debt$32.1m, Q1 FY2026
Shareholders' equity$16.3m, Q2 FY2026
Werewolf Therapeutics, Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m130Cash and equivalents, Q3 FY2023, at 2023-09-30$130.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-07, accession 0001785530-24-000034.Report this figure134Cash and equivalents, FY2023, at 2023-12-31$134.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-11, accession 0001785530-25-000008.Report this figure139Cash and equivalents, Q1 FY2024, at 2024-03-31$139.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-08, accession 0001785530-25-000014.Report this figure135Cash and equivalents, Q2 FY2024, at 2024-06-30$135.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-14, accession 0001785530-25-000021.Report this figure123Cash and equivalents, Q3 FY2024, at 2024-09-30$122.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-04, accession 0001785530-25-000031.Report this figure111Cash and equivalents, FY2024, at 2024-12-31$111.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-27, accession 0001785530-26-000006.Report this figure92.0Cash and equivalents, Q1 FY2025, at 2025-03-31$92.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-07, accession 0001785530-26-000012.Report this figure77.6Cash and equivalents, Q2 FY2025, at 2025-06-30$77.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-07-31, accession 0001785530-26-000019.Report this figure65.7Cash and equivalents, Q3 FY2025, at 2025-09-30$65.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-04, accession 0001785530-25-000031.Report this figure57.1Cash and equivalents, FY2025, at 2025-12-31$57.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-07-31, accession 0001785530-26-000019.Report this figure46.5Cash and equivalents, Q1 FY2026, at 2026-03-31$46.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-07, accession 0001785530-26-000012.Report this figure22.0Cash and equivalents, Q2 FY2026, at 2026-06-30$22.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-07-31, accession 0001785530-26-000019.Report this figure
Current assets$m139Current assets, Q3 FY2023, at 2023-09-30$139.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-14, accession 0001785530-23-000033.Report this figure138Current assets, FY2023, at 2023-12-31$138.4m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-11, accession 0001785530-25-000008.Report this figure142Current assets, Q1 FY2024, at 2024-03-31$142.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-03, accession 0001785530-24-000020.Report this figure139Current assets, Q2 FY2024, at 2024-06-30$138.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-08, accession 0001785530-24-000028.Report this figure126Current assets, Q3 FY2024, at 2024-09-30$125.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-07, accession 0001785530-24-000034.Report this figure113Current assets, FY2024, at 2024-12-31$113.1m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-27, accession 0001785530-26-000006.Report this figure94.5Current assets, Q1 FY2025, at 2025-03-31$94.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-08, accession 0001785530-25-000014.Report this figure80.4Current assets, Q2 FY2025, at 2025-06-30$80.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-14, accession 0001785530-25-000021.Report this figure68.2Current assets, Q3 FY2025, at 2025-09-30$68.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-04, accession 0001785530-25-000031.Report this figure58.6Current assets, FY2025, at 2025-12-31$58.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-07-31, accession 0001785530-26-000019.Report this figure48.7Current assets, Q1 FY2026, at 2026-03-31$48.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-07, accession 0001785530-26-000012.Report this figure22.9Current assets, Q2 FY2026, at 2026-06-30$22.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-07-31, accession 0001785530-26-000019.Report this figure
Total assets$m176Total assets, Q3 FY2023, at 2023-09-30$176.4m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-14, accession 0001785530-23-000033.Report this figure175Total assets, FY2023, at 2023-12-31$174.8m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-11, accession 0001785530-25-000008.Report this figure178Total assets, Q1 FY2024, at 2024-03-31$177.6m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-03, accession 0001785530-24-000020.Report this figure154Total assets, Q2 FY2024, at 2024-06-30$153.7m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-08, accession 0001785530-24-000028.Report this figure140Total assets, Q3 FY2024, at 2024-09-30$140.0m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-07, accession 0001785530-24-000034.Report this figure127Total assets, FY2024, at 2024-12-31$126.9m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-27, accession 0001785530-26-000006.Report this figure107Total assets, Q1 FY2025, at 2025-03-31$107.2m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-08, accession 0001785530-25-000014.Report this figure92.6Total assets, Q2 FY2025, at 2025-06-30$92.6m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-14, accession 0001785530-25-000021.Report this figure79.6Total assets, Q3 FY2025, at 2025-09-30$79.6m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-04, accession 0001785530-25-000031.Report this figure69.4Total assets, FY2025, at 2025-12-31$69.4m. XBRL concept us-gaap:Assets. 10-Q filed 2026-07-31, accession 0001785530-26-000019.Report this figure58.0Total assets, Q1 FY2026, at 2026-03-31$58.0m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-07, accession 0001785530-26-000012.Report this figure24.2Total assets, Q2 FY2026, at 2026-06-30$24.2m. XBRL concept us-gaap:Assets. 10-Q filed 2026-07-31, accession 0001785530-26-000019.Report this figure
Current liabilities$m14.4Current liabilities, Q3 FY2023, at 2023-09-30$14.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-14, accession 0001785530-23-000033.Report this figure19.4Current liabilities, FY2023, at 2023-12-31$19.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-11, accession 0001785530-25-000008.Report this figure21.2Current liabilities, Q1 FY2024, at 2024-03-31$21.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-03, accession 0001785530-24-000020.Report this figure11.4Current liabilities, Q2 FY2024, at 2024-06-30$11.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-08, accession 0001785530-24-000028.Report this figure12.5Current liabilities, Q3 FY2024, at 2024-09-30$12.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-07, accession 0001785530-24-000034.Report this figure15.2Current liabilities, FY2024, at 2024-12-31$15.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-27, accession 0001785530-26-000006.Report this figure11.7Current liabilities, Q1 FY2025, at 2025-03-31$11.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-08, accession 0001785530-25-000014.Report this figure15.2Current liabilities, Q2 FY2025, at 2025-06-30$15.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-14, accession 0001785530-25-000021.Report this figure17.6Current liabilities, Q3 FY2025, at 2025-09-30$17.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-04, accession 0001785530-25-000031.Report this figure36.1Current liabilities, FY2025, at 2025-12-31$36.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-07-31, accession 0001785530-26-000019.Report this figure38.5Current liabilities, Q1 FY2026, at 2026-03-31$38.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-07, accession 0001785530-26-000012.Report this figure7.9Current liabilities, Q2 FY2026, at 2026-06-30$7.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-07-31, accession 0001785530-26-000019.Report this figure
Total liabilities$m63.9Total liabilities, Q3 FY2023, at 2023-09-30$63.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-14, accession 0001785530-23-000033.Report this figure63.5Total liabilities, FY2023, at 2023-12-31$63.5m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-11, accession 0001785530-25-000008.Report this figure60.0Total liabilities, Q1 FY2024, at 2024-03-31$60.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-03, accession 0001785530-24-000020.Report this figure49.7Total liabilities, Q2 FY2024, at 2024-06-30$49.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-08, accession 0001785530-24-000028.Report this figure50.7Total liabilities, Q3 FY2024, at 2024-09-30$50.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-07, accession 0001785530-24-000034.Report this figure53.5Total liabilities, FY2024, at 2024-12-31$53.5m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-27, accession 0001785530-26-000006.Report this figure49.9Total liabilities, Q1 FY2025, at 2025-03-31$49.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-08, accession 0001785530-25-000014.Report this figure51.1Total liabilities, Q2 FY2025, at 2025-06-30$51.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-14, accession 0001785530-25-000021.Report this figure50.0Total liabilities, Q3 FY2025, at 2025-09-30$50.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-04, accession 0001785530-25-000031.Report this figure44.6Total liabilities, FY2025, at 2025-12-31$44.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-07-31, accession 0001785530-26-000019.Report this figure45.8Total liabilities, Q1 FY2026, at 2026-03-31$45.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-07, accession 0001785530-26-000012.Report this figure7.9Total liabilities, Q2 FY2026, at 2026-06-30$7.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-07-31, accession 0001785530-26-000019.Report this figure
Long-term debt$mnot reported40.0Long-term debt, FY2023, at 2023-12-31$40.0m. XBRL concept us-gaap:LongTermDebt. 10-K filed 2024-03-07, accession 0001785530-24-000012.Report this figure40.0Long-term debt, Q1 FY2024, at 2024-03-31$40.0m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2024-05-03, accession 0001785530-24-000020.Report this figure32.1Long-term debt, Q2 FY2024, at 2024-06-30$32.1m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2024-08-08, accession 0001785530-24-000028.Report this figure32.1Long-term debt, Q3 FY2024, at 2024-09-30$32.1m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2024-11-07, accession 0001785530-24-000034.Report this figure32.1Long-term debt, FY2024, at 2024-12-31$32.1m. XBRL concept us-gaap:LongTermDebt. 10-K filed 2025-03-11, accession 0001785530-25-000008.Report this figure32.1Long-term debt, Q1 FY2025, at 2025-03-31$32.1m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2025-05-08, accession 0001785530-25-000014.Report this figure32.1Long-term debt, Q2 FY2025, at 2025-06-30$32.1m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2025-08-14, accession 0001785530-25-000021.Report this figure32.1Long-term debt, Q3 FY2025, at 2025-09-30$32.1m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2025-11-04, accession 0001785530-25-000031.Report this figure32.1Long-term debt, FY2025, at 2025-12-31$32.1m. XBRL concept us-gaap:LongTermDebt. 10-K filed 2026-03-27, accession 0001785530-26-000006.Report this figure32.1Long-term debt, Q1 FY2026, at 2026-03-31$32.1m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2026-05-07, accession 0001785530-26-000012.Report this figurenot reported
Shareholders' equity$m112Shareholders' equity, Q3 FY2023, at 2023-09-30$112.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-07, accession 0001785530-24-000034.Report this figure111Shareholders' equity, FY2023, at 2023-12-31$111.4m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-27, accession 0001785530-26-000006.Report this figure118Shareholders' equity, Q1 FY2024, at 2024-03-31$117.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-04, accession 0001785530-25-000031.Report this figure104Shareholders' equity, Q2 FY2024, at 2024-06-30$104.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-04, accession 0001785530-25-000031.Report this figure89.4Shareholders' equity, Q3 FY2024, at 2024-09-30$89.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-04, accession 0001785530-25-000031.Report this figure73.4Shareholders' equity, FY2024, at 2024-12-31$73.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-31, accession 0001785530-26-000019.Report this figure57.3Shareholders' equity, Q1 FY2025, at 2025-03-31$57.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-31, accession 0001785530-26-000019.Report this figure41.5Shareholders' equity, Q2 FY2025, at 2025-06-30$41.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-31, accession 0001785530-26-000019.Report this figure29.6Shareholders' equity, Q3 FY2025, at 2025-09-30$29.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-04, accession 0001785530-25-000031.Report this figure24.8Shareholders' equity, FY2025, at 2025-12-31$24.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-31, accession 0001785530-26-000019.Report this figure12.2Shareholders' equity, Q1 FY2026, at 2026-03-31$12.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-31, accession 0001785530-26-000019.Report this figure16.3Shareholders' equity, Q2 FY2026, at 2026-06-30$16.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-31, accession 0001785530-26-000019.Report this figure

Cash flow

Operating cash flow$6.6m, Q2 FY2026
Capital expenditure$0, Q4 FY2025
Werewolf Therapeutics, Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(7.2)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$7.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-07, accession 0001785530-24-000034. Derived: 9-month figure less the 6-month figure.Report this figure(4.6)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$4.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-11, accession 0001785530-25-000008. Derived: 12-month figure less the 9-month figure.Report this figure(15.3)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$15.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-08, accession 0001785530-25-000014.Report this figure(14.2)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$14.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-14, accession 0001785530-25-000021. Derived: 6-month figure less the 3-month figure.Report this figure(12.5)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$12.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-04, accession 0001785530-25-000031. Derived: 9-month figure less the 6-month figure.Report this figure(14.3)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$14.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-27, accession 0001785530-26-000006. Derived: 12-month figure less the 9-month figure.Report this figure(18.9)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$18.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001785530-26-000012.Report this figure(15.2)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$15.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-07-31, accession 0001785530-26-000019. Derived: 6-month figure less the 3-month figure.Report this figure(15.2)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$15.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-04, accession 0001785530-25-000031. Derived: 9-month figure less the 6-month figure.Report this figure(11.0)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$11.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-27, accession 0001785530-26-000006. Derived: 12-month figure less the 9-month figure.Report this figure(10.6)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$10.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001785530-26-000012.Report this figure6.6Operating cash flow, Q2 FY2026, three months to 2026-06-30$6.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-07-31, accession 0001785530-26-000019. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.2Capital expenditure, Q3 FY2023, three months to 2023-09-30$221.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-07, accession 0001785530-24-000034. Derived: 9-month figure less the 6-month figure.Report this figure0.2Capital expenditure, Q4 FY2023, three months to 2023-12-31$198.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-11, accession 0001785530-25-000008. Derived: 12-month figure less the 9-month figure.Report this figure0.1Capital expenditure, Q1 FY2024, three months to 2024-03-31$111.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-08, accession 0001785530-25-000014.Report this figure0.0Capital expenditure, Q2 FY2024, three months to 2024-06-30$17.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-14, accession 0001785530-25-000021. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, Q3 FY2024, three months to 2024-09-30$3.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-04, accession 0001785530-25-000031. Derived: 9-month figure less the 6-month figure.Report this figure0.1Capital expenditure, Q4 FY2024, three months to 2024-12-31$123.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-27, accession 0001785530-26-000006. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-08, accession 0001785530-25-000014.Report this figure0.0Capital expenditure, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-14, accession 0001785530-25-000021. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-04, accession 0001785530-25-000031. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-27, accession 0001785530-26-000006. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reported

Shares

Diluted shares (weighted)48.60m, Q2 FY2026
Werewolf Therapeutics, Inc., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares29.8Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3029,764,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-14, accession 0001785530-23-000033.Report this figure34.8Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3134,784,682 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-03, accession 0001785530-24-000020.Report this figure35.6Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3035,557,701 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-08, accession 0001785530-24-000028.Report this figure35.7Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3035,653,924 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-07, accession 0001785530-24-000034.Report this figure41.6Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3141,607,279 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-08, accession 0001785530-25-000014.Report this figure44.0Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3044,043,184 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-14, accession 0001785530-25-000021.Report this figure43.7Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3043,704,836 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-04, accession 0001785530-25-000031.Report this figure44.8Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3144,827,159 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-07, accession 0001785530-26-000012.Report this figure45.0Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3044,981,746 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-07-31, accession 0001785530-26-000019.Report this figure45.8Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3045,804,042 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-04, accession 0001785530-25-000031.Report this figure49.4Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3149,388,181 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-07, accession 0001785530-26-000012.Report this figure48.6Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3048,597,534 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-07-31, accession 0001785530-26-000019.Report this figure

Shares outstanding: 48.60mShares outstanding, period not labelled, at 2026-07-2748,599,066 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-07-31, accession 0001785530-26-000019.Report this figure at Jul 27, 2026, from the cover of the 10-Q filed Jul 31, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:47 ET. Listed shows no prices and gives no investment advice.